Recent advancements in diabetes treatment have brought forth a new generation of medications known as GLP-1 receptor agonists. These compounds work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a hormone https://ztndz.com/story26814822/glp-1-receptor-agonists-retaglutide-retatrutide-and-tirzepatide